Validation of lysyl oxidase-like 2 (LOXL2) as prognostic marker for gastro-entero-pancreatic neuroendocrine tumours (GEP-NET) Using an independent cohort
Authors
Barriuso, JorgeBenavent, M
Lamarca, Angela
Bernal, E
Guerra-Pastrian, L
Heredia, V
Miguel, V
Garcia-Calderon, C
Alvarez-Escola, C
Castell, J
Custodio, A
Burgos, E
Feliu, J
Carbonero, G
Mendiola, M
Affiliation
University of Manchester, Manchester, UKIssue Date
2016